Picture of Sihuan Pharmaceutical Holdings logo

460 Sihuan Pharmaceutical Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Sihuan Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line486-2,123-161-428417
Depreciation
Amortisation
Non-Cash Items2911,819117528109
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-414-11.627.3-102-764
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities66546.5199244-23.6
Capital Expenditures-726-594-295-186-195
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items388-1,067465945-102
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-338-1,661170758-296
Financing Cash Flow Items860924-55.823.7645
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities751-239-420-1,258358
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,078-1,854-50.2-25638.1